HIGHLIGHTS
- who: Ella A. Eklund et al. from the Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Wallenberg Centre for Molecular and Translational Medicine, University of have published the Article: KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer, in the Journal: (JOURNAL)
- what: Although this study provides real-world evidence of the impact of KRAS mutational status on first-line therapy in a large and well-controlled group of Stage IV NSCLC patients, it is obviously limited by its retrospective nature.
- how: The authors conducted a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.